Brief: Qlife Submits Egoo PHE For Regulatory Approval
Jan 26 (Reuters) - Qlife Holding AB QLIFE.ST: SUBMITS EGOO PHE FOR REGULATORY APPROVAL APPROVAL TO ENABLE COMMERCIALIZATION IN EU AND UK MARKETS Source text: ID:nWkr8ZFsLk Further company coverage: QLIFE.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Qlife Holding AB
See all newsAdvisory: Alerts on Qlife's agreement with global pharma company withdrawn
Brief: Qlife Holding Enters Feasibility Deal With Pharma Co For Egoo Health Biomarker
Brief: Qlife Holding Q1 EBITDA Loss SEK 5.5 Mln
Sweden's Qlife Q1 revenue drops, losses widen slightly
Brief: Qlife Holding Q4 EBITDA At SEK -1.6 Million